HUP9903839A2 - Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence - Google Patents

Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence

Info

Publication number
HUP9903839A2
HUP9903839A2 HU9903839A HUP9903839A HUP9903839A2 HU P9903839 A2 HUP9903839 A2 HU P9903839A2 HU 9903839 A HU9903839 A HU 9903839A HU P9903839 A HUP9903839 A HU P9903839A HU P9903839 A2 HUP9903839 A2 HU P9903839A2
Authority
HU
Hungary
Prior art keywords
desethyloxybutynin
oxybutynin
urinary incontinence
treatment
pharmaceutical compositions
Prior art date
Application number
HU9903839A
Other languages
Hungarian (hu)
Inventor
Gunnar Aberg
John R. Mccullough
Original Assignee
Sepracor Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/671,976 external-priority patent/US5736577A/en
Application filed by Sepracor Inc. filed Critical Sepracor Inc.
Publication of HUP9903839A2 publication Critical patent/HUP9903839A2/en
Publication of HUP9903839A3 publication Critical patent/HUP9903839A3/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Treating urinary incontinence while avoiding concomitant liability of adverse effects comprises administration of 100 mg/day - 1 g/day (S)-oxybutynin (I) or (S)-desethyloxybutynin (II) or their salts. Also claimed are a transdermal delivery device or tablets or a soft elastic gelatin capsules comprising a carrier and 0.1-500 mg (I) or (II) or their salts.
HU9903839A 1970-12-11 1997-06-27 Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence HUP9903839A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9711570A 1970-12-11 1970-12-11
US08/671,976 US5736577A (en) 1995-01-31 1996-06-28 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin

Publications (2)

Publication Number Publication Date
HUP9903839A2 true HUP9903839A2 (en) 2000-03-28
HUP9903839A3 HUP9903839A3 (en) 2000-04-28

Family

ID=26792614

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903839A HUP9903839A3 (en) 1970-12-11 1997-06-27 Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence

Country Status (1)

Country Link
HU (1) HUP9903839A3 (en)

Also Published As

Publication number Publication date
HUP9903839A3 (en) 2000-04-28

Similar Documents

Publication Publication Date Title
JPS51118839A (en) Amino acid pharmacy for liverish patient dosage
RU99101790A (en) METHOD FOR TREATING URINE INCOMPOSITION USING (S) -OXIBUTININ AND (S) -DESETHYLOXIBUTININ
ES2051881T3 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE.
ES2035821T3 (en) INTEGRATED DIRECTED ADMINISTRATION SYSTEM.
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
GB1390803A (en) Medicinal tampons and compositions containing lactulose
ES469878A1 (en) Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
IE42950L (en) X-ray contrast preparations
PH9997A (en) Pharmacologically active n(1h-tetrazol-5-yl)quinaldamide compounds and compositions containing them
HUP9903839A2 (en) Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence
BE827595A (en) MEDICINAL PRODUCT FOR ORAL ADMINISTRATION PRODUCING AN ANTIPLASMINE INHIBITOR EFFECT
ZA703978B (en) Device for subcutaneous administration of biologically active substances
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ATE85218T1 (en) ORAL PHARMACEUTICAL FORM FOR THE TREATMENT OF HYPERTENSION WITH DILTIAZEM HYDROCHLORIDE ONCE DAILY.
GB904955A (en) Pharmaceutical compositions containing phloroglucinol
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
FR2345146A1 (en) Anorexigenic and lipolytic agent - contg. hydroxy-indanyl propanol for treating obesity
GB914512A (en) Novel therapeutic compositions
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
IE36780L (en) Pharmaceutical preparations
FR2077913A1 (en) Tablets contg gelatine capsules - for administration of liquid medicaments
GR3002199T3 (en) Medicaments containing n-alkyl scopol amine salt and nitroglycerine, method for its preparation and its use
ES370500A1 (en) Procedure for the preparation of the hydracide. (Machine-translation by Google Translate, not legally binding)
AU426565B2 (en) Bandage for administering drugs
GB992956A (en) Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees